Inspire Medical officer reports 587-share tax withholding

Inspire Medical Systems, Inc. officer John Rondoni reported a tax-related share disposition.

Rhea-AI Filing Summary

Inspire Medical Systems, Inc. officer John Rondoni reported a tax-related share disposition. On February 13, 2026, the company withheld 587 shares of common stock at $59.76 per share to cover taxes due on the vesting of a restricted stock unit award. After this withholding, Rondoni directly owned 12,883 common shares. This was a tax-withholding transaction, not an open-market sale.

Insider Trade Summary

Exercise Price or Tax Liability: 587 shares

Exercise Price or Tax Liability 1 txn

Insider Rondoni John

Role See Remarks

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	587	$59.76	$35K

Holdings After Transaction: Common Stock — 12,883 shares (Direct)

Footnotes (1)

1. F1. Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Inspire Medical Systems (INSP) report for John Rondoni?

Inspire Medical Systems officer John Rondoni reported a tax-withholding disposition of 587 common shares. These shares were withheld by the company to cover taxes on vesting restricted stock units, rather than sold in the open market.

How many Inspire Medical Systems (INSP) shares were disposed of and at what price?

The filing shows 587 shares of Inspire Medical Systems common stock were disposed of at $59.76 per share. The transaction was coded as a tax-related withholding, not a conventional open-market trade or discretionary sale by the insider.

Why were Inspire Medical Systems (INSP) shares withheld from John Rondoni?

The shares were withheld to satisfy taxes triggered by the vesting of a restricted stock unit award. Instead of paying cash for the tax liability, a portion of the vested shares was retained by Inspire Medical Systems to cover the tax obligation.

How many Inspire Medical Systems (INSP) shares does John Rondoni hold after this transaction?

After the reported tax-withholding disposition, John Rondoni directly owns 12,883 shares of Inspire Medical Systems common stock. This post-transaction balance reflects the remaining equity following the withholding of 587 shares to cover associated tax liabilities.

Was the Inspire Medical Systems (INSP) Form 4 transaction an open-market sale?

No, the transaction was not an open-market sale. It was coded as F, meaning shares were withheld by the issuer to pay taxes on restricted stock unit vesting, a routine administrative event rather than a discretionary sale into the market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/18/2026 - 04:07 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rondoni John

(Last) (First) (Middle)

C/O INSPIRE MEDICAL SYSTEMS, INC.

5500 WAYZATA BLVD., SUITE 1600

(Street)

GOLDEN VALLEY MN 55416

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Inspire Medical Systems, Inc. [ INSP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/13/2026		F		587(1)	D	$59.76	12,883	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award.

Remarks:

Title: Chief Product and Innovation Officer. Exhibit 24 - Power of Attorney.

	/s/ Bryan Phillips, Attorney-in-Fact for John Rondoni	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.